Competitive: Barrington James: Medical Lead - Neurology SUMMARY: The Medical Lead, Clinical Development will assume a pivotal role in shaping the...
Vous n'êtes pas connecté
GREENVILLE, S.C. — Avallano, an AI-enabled clinical research company, today announced the appointment of Michael A. Ibara, Pharm.D., as Chief Strategy Officer (CSO). Dr. Ibara will lead the company’s global strategic initiatives to transform the clinical trial sector with leading-edge technology solutions. Dr. Ibara will lead the launch of Avallano’s generative AI technologies, aimed at […]
Competitive: Barrington James: Medical Lead - Neurology SUMMARY: The Medical Lead, Clinical Development will assume a pivotal role in shaping the...
Pharos Energy, an independent energy company, has announced the appointment of Katherine Roe as the Company's new Chief Executive Officer (CEO) with...
Generative AI (GenAI)-enabled software development will improve productivity and work efficiency – the question is, how much? Most market research...
Last year, Mastercard chief marketing and communications officer Raja Rajamannar invited the company's chief financial officer, Sachin Mehra, to...
Australian cyber security business CSO Group will merge with automation systems and artificial intelligence integrator xAmplify. Once complete, the...
Bermudian-based Phil Schmidt has been appointed chief strategy officer of Markel, the insurance operations within Markel Group Inc. The company said...
Image: Henri Koskinen/stock.adobe.comCore Lithium has announced the permanent appointment of James Virgo as chief financial officer (CFO). Virgo has...
Firm’s First Dedicated Team in Canada Includes Research Head Fred Blondeau and Six News Reporters Covering the Country NEWPORT BEACH,...